AlphaStocks
5.0
Consider Buy

Centene Corp (CNC)

As of Sep 20, 2026, Centene Corp (CNC) scores 5.0/10 on AlphaStocks' five-model composite, #114 of 168 Health Care stocks. At $65, CNC trades 17% below its model fair value of $79.

Health Care / Managed Health Care

S&P 500

$65.11

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#114out of 168 in Health Care

Is CENTENE CORP a Good Investment in 2026?

CENTENE CORP (CNC) scores 5.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates CENTENE CORP as Attractive. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -23.3% · ROC -134%. CENTENE CORP currently trades 17% below its estimated fair value of $79. CENTENE CORP ranks #114 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-32.6Market Cap32B

Estimated Fair Value

$78.8817% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -23.3% · ROC -134%

Frequently Asked Questions

Is CENTENE CORP (CNC) a good investment?
As of Sep 20, 2026, Centene Corp (CNC) scores 5.0/10 on AlphaStocks' five-model composite, #114 of 168 Health Care stocks. At $65, CNC trades 17% below its model fair value of $79. That score is below average, suggesting caution.
What is CENTENE CORP's Piotroski F-Score?
CENTENE CORP's Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CNC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $79, CNC appears undervalued. The stock currently trades 17% below its estimated fair value. Trading below estimated fair value.
How does CNC compare to other Health Care stocks?
CENTENE CORP ranks #114 out of 168 stocks in the Health Care sector, placing it in the top 68% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CNC?
AlphaStocks evaluates CNC using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Caution; Lynch: Attractive; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.0/10.

Similar Stocks

Compare CNC with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer